Immunostaining with anti-luciferase antibody confirmed that HepG2/NF-κB/Luc cells had been transplanted successfully in livers and a markedly lower number of luciferase-positive cells in ZJW-treated groups relative to control was observed, indicating that ZJW was a potent anti-cancer agent in vivo. Here, NFKB1 is linked to cancer.